logo-loader
viewBiotron Ltd

Full interview: Biotron share price on the move as coronavirus fears increase

Biotron Limited (ASX:BIT) updates Proactive on the company's buoyant share price, which is partly due to escalating concerns about the coronavirus.

The clinical stage biotech company focuses on potential breakthrough treatments for serious viruses, including HIV-1 and Hepatitis B, and is also working on how to tackle new health scares like coronavirus and others.

Quick facts: Biotron Ltd

Price: 0.1 AUD

ASX:BIT
Market: ASX
Market Cap: $70.19 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus Ltd 'in good shape' with minimal disruption to supply chain as it...

Admedus Ltd's (ASX:AHZ) Wayne Paterson caught up with Proactive's Andrew Scott to discuss the steps and precautions the firm's taking in the wake of the recent virus outbreak. The company's just announced the hospital discharge of the first patient following its clinical surgical aortic valve...

3 hours, 21 minutes ago

2 min read